BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17911455)

  • 1. Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses.
    Reinhold D; Biton A; Goihl A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Ann N Y Acad Sci; 2007 Sep; 1110():402-9. PubMed ID: 17911455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
    Reinhold D; Biton A; Pieper S; Lendeckel U; Faust J; Neubert K; Bank U; Täger M; Ansorge S; Brocke S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1935-42. PubMed ID: 17161346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
    Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PETIR-001, a dual inhibitor of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN), ameliorates experimental autoimmune encephalomyelitis in SJL/J mice.
    Reinhold D; Bank U; Entz D; Goihl A; Stoye D; Wrenger S; Brocke S; Thielitz A; Stefin S; Nordhoff K; Heimburg A; Täger M; Ansorge S
    Biol Chem; 2011 Mar; 392(3):233-7. PubMed ID: 21194377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases.
    Kühlmann UC; Chwieralski CE; van den Brule S; Röcken C; Reinhold D; Welte T; Bühling F
    Life Sci; 2009 Jan; 84(1-2):1-11. PubMed ID: 18973761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent actions by inhibitors of DP IV and APN family enzymes on CD4+ Teff cell motility and functions.
    Biton A; Ansorge S; Bank U; Täger M; Reinhold D; Brocke S
    Immunobiology; 2011 Dec; 216(12):1295-301. PubMed ID: 21802166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions.
    Ansorge S; Bank U; Heimburg A; Helmuth M; Koch G; Tadje J; Lendeckel U; Wolke C; Neubert K; Faust J; Fuchs P; Reinhold D; Thielitz A; Täger M
    Clin Chem Lab Med; 2009; 47(3):253-61. PubMed ID: 19327105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity.
    Reinhold D; Kähne T; Steinbrecher A; Wrenger S; Neubert K; Ansorge S; Brocke S
    Biol Chem; 2002; 383(7-8):1133-8. PubMed ID: 12437097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis.
    Reinhold D; Bank U; Täger M; Ansorge S; Wrenger S; Thielitz A; Lendeckel U; Faust J; Neubert K; Brocke S
    Front Biosci; 2008 Jan; 13():2356-63. PubMed ID: 17981717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
    Thielitz A; Reinhold D; Vetter R; Bank U; Helmuth M; Hartig R; Wrenger S; Wiswedel I; Lendeckel U; Kähne T; Neubert K; Faust J; Zouboulis CC; Ansorge S; Gollnick H
    J Invest Dermatol; 2007 May; 127(5):1042-51. PubMed ID: 16778789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.
    Reinhold D; Goihl A; Wrenger S; Reinhold A; Kühlmann UC; Faust J; Neubert K; Thielitz A; Brocke S; Täger M; Ansorge S; Bank U
    Clin Chem Lab Med; 2009; 47(3):268-74. PubMed ID: 19676138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro.
    Schön E; Jahn S; Kiessig ST; Demuth HU; Neubert K; Barth A; Von Baehr R; Ansorge S
    Eur J Immunol; 1987 Dec; 17(12):1821-6. PubMed ID: 2891539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines and glucocorticoids differentially regulate APN/CD13 and DPPIV/CD26 enzyme activities in cultured human dermal fibroblasts.
    Sorrell JM; Brinon L; Baber MA; Caplan AI
    Arch Dermatol Res; 2003 Aug; 295(4):160-8. PubMed ID: 12861419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-beta(1).
    Arndt M; Lendeckel U; Spiess A; Faust J; Neubert K; Reinhold D; Ansorge S
    Biochem Biophys Res Commun; 2000 Aug; 274(2):410-4. PubMed ID: 10913352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoelectron microscopic demonstration of the membrane proteases aminopeptidase N/CD13 and dipeptidyl peptidase IV/CD26 in normal and neoplastic renal parenchymal tissues and cells.
    Stange T; Kettmann U; Holzhausen HJ
    Eur J Histochem; 2000; 44(2):157-64. PubMed ID: 10968363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
    Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
    Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation.
    Kähne T; Kröning H; Thiel U; Ulmer AJ; Flad HD; Ansorge S
    Cell Immunol; 1996 May; 170(1):63-70. PubMed ID: 8660800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.
    Bauvois B; Puiffe ML; Bongui JB; Paillat S; Monneret C; Dauzonne D
    J Med Chem; 2003 Aug; 46(18):3900-13. PubMed ID: 12930151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.
    Thielitz A; Ansorge S; Bank U; Tager M; Wrenger S; Gollnick H; Reinhold D
    Front Biosci; 2008 Jan; 13():2364-75. PubMed ID: 17981718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-bound peptidases of lymphocytes: functional implications.
    Ansorge S; Schön E; Kunz D
    Biomed Biochim Acta; 1991; 50(4-6):799-807. PubMed ID: 1686972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.